Chris Heminway, Exec-Chair at Time To ACT, explains why now is the right time for the Group to IPO. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFocusrite Regulatory News (TUNE)

Share Price Information for Focusrite (TUNE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 380.00
Bid: 370.00
Ask: 390.00
Change: 0.00 (0.00%)
Spread: 20.00 (5.405%)
Open: 370.00
High: 0.00
Low: 0.00
Prev. Close: 380.00
TUNE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

PDMR Dealings - amendment

3 Oct 2022 18:12

RNS Number : 6301B
Focusrite PLC
03 October 2022
 

For immediate release

 

An amendment has been made to the RNS announcement number 8706T released on 29 November 2021 at 09:48:53.

The following correction has been made to Tim Dingley's total shareholding in the fourth paragraph. 

The text now reads:

"Following the transaction:

Mr. Dingley will have a beneficial holding of 246,472 Ordinary Shares which represents 0.42% of the current issued share capital."

All other details remain unchanged. The full amended text is show below.

 

 

 

 

PDMR Dealings

FOCUSRITE PLC

Released 09:48:53 29 November 2021

 

RNS Number : 8706T

Focusrite PLC

29 November 2021

 

Focusrite plc

 

("the Company" or "the Group")

 

 PDMR Dealings

Settlement of Share Options

 

Focusrite plc (AIM:TUNE), the global music and audio products company that trades under the Focusrite and Novation brands, announces that on 25 November 2021 Tim Dingley, a Person Discharging Managerial Responsibilities ("PDMRs"), exercised nominal cost options over 15,919 shares granted to him under the Company's Performance Share Plan and acquired ordinary shares of 0.1p each in the Company.

 

The option was granted on 21 November 2018 and became vested and exercisable as from 22 November 2021.

 

The exercise of the option was settled in part by the transfer of 8,437 ordinary shares and in part with a cash payment equal to market value of 7,482 ordinary shares to meet the PDMR's liability to income tax and employee national insurance arising on the exercise of the option.

 

Following the transaction:

Mr. Dingley will have a beneficial holding of 246,472 Ordinary Shares which represents 0.42% of the current issued share capital.

 

The information set out below is provided in accordance with the requirements of Article 19(3) of the Market Abuse Regulation (EU) No 596/2014.

1

Details of the persons discharging managerial responsibilities person closely associated

a)

Name

 Tim Dingley

2

Reason for the notification

a)

Position/status

 Chief Operating Officer

b)

Initial notification /Amendment

 Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Focusrite plc

b)

LEI

213800JJ51KA4LOTF736

4A

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary Shares of 0.1p each in Focusrite plc

Identification code

GB00BSBMW716

b)

Nature of the transaction

Exercise of a nominal cost option under the Focusrite plc Performance Share Plan and acquisition of ordinary shares of 0.1p each in Focusrite plc (or, as to 47% of the vested shares number, cash in lieu of such shares).

c)

Price(s) and volume(s)

 

Price(s)

Volumes

£ 15.92

15,919 (settled in part by the transfer of 8,437 ordinary shares and in part with a cash payment equal to market value of 7,482 ordinary shares to meet the PDMR's liability to income tax and employee national insurance arising on the exercise of the option over 15,919 shares)

 

d)

Aggregated information

- Aggregated volume 

- Price 

Not applicable - single transaction

e)

Date of the transaction

25 November 2021

f)

Place of the transaction

Outside a trading venue

4B

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary Shares of 0.1p each in Focusrite plc

Identification code

GB00BSBMW716

b)

Nature of the transaction

Transfer of shares to Janice Dingley (spouse) for nil consideration

c)

Price(s) and volume(s)

 

Price(s)

Volumes

Nil

8,437

d)

Aggregated information

- Aggregated volume 

- Price 

Not applicable - single transaction

e)

Date of the transaction

25 November 2021

f)

Place of the transaction

Outside a trading venue

 

 

 

-ends-

Focusrite plc:

Tim Carroll (CEO)

+44 1494 462246

Sally McKone (CFO)

+44 1494 462246

Investec Bank plc (Nominated Adviser and Joint Broker)

+44 (0) 20 7597 5970

David Flin

William Brinkley

Charlotte Young

Peel Hunt LLP (Joint Broker)

+44 (0) 20 7418 8900

Edward Knight

 

Michael Burke

 

James Smith

 

Belvedere Communications

John West

+44 20 3687 2753

Llew Angus

+44 20 3687 2754

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUPGBUUUPPGMW
Date   Source Headline
4th Dec 20202:52 pmRNSSettlement of Share Options
1st Dec 20203:47 pmRNSSettlement of Share Options
25th Nov 20206:02 pmRNSNotification of PDMR Transactions
19th Nov 20203:54 pmRNSDirectors’ Dealings
18th Nov 20201:57 pmRNSDirector Share Dealings
17th Nov 20207:00 amRNSFinal Results for the Year Ended 31 August 2020
4th Nov 20207:00 amRNSNotice of Final Results
14th Sep 20204:40 pmRNSSecond Price Monitoring Extn
14th Sep 20204:35 pmRNSPrice Monitoring Extension
14th Sep 20202:06 pmRNSSecond Price Monitoring Extn
14th Sep 20202:01 pmRNSPrice Monitoring Extension
14th Sep 202011:05 amRNSSecond Price Monitoring Extn
14th Sep 202011:00 amRNSPrice Monitoring Extension
14th Sep 20209:05 amRNSSecond Price Monitoring Extn
14th Sep 20209:00 amRNSPrice Monitoring Extension
14th Sep 20207:00 amRNSTrading Update
1st Sep 20207:00 amRNSAppointment of new CFO
3rd Aug 20207:00 amRNSPayment of Interim Dividend
10th Jul 20207:00 amRNSTrading Statement
14th May 20207:00 amRNSDirectors' Dealings
12th May 20207:00 amRNSHalf Year Results
24th Apr 20203:13 pmRNSNotice of Results
18th Mar 20207:30 amRNSTrading Update and Directorate Change
30th Jan 20201:41 pmRNSDirector/PDMR Dealings
28th Jan 202012:28 pmRNSSettlement of Share Options
22nd Jan 20207:00 amRNSTR-1
15th Jan 20205:49 pmRNSSettlement of Share Options
14th Jan 202011:08 amRNSDirector/PDMR Dealings
3rd Jan 20202:47 pmRNSGrant of Share Options to Directors
3rd Jan 20202:40 pmRNSDirectors' Dealings
3rd Jan 20202:36 pmRNSSettlement of Share Options
30th Dec 201912:00 pmRNSCompletion of Acquisition of Martin Audio Ltd
30th Dec 201910:15 amRNSResult of General Meeting
27th Dec 20197:00 amRNSDirector Share Dealings
20th Dec 201912:37 pmRNSResult of 2019 AGM
20th Dec 20197:00 amRNSAGM Statement and Update on Trading
19th Dec 20197:00 amRNSAcquisition of Martin Audio Ltd
13th Dec 20192:10 pmRNSCircular Publication and Notice of General Meeting
19th Nov 20197:00 amRNSFinal Results for the Year Ended 31 August 2019
16th Sep 20193:09 pmRNSTR-1
12th Sep 20197:00 amRNSTrading update for the year ending 31 August 2019
23rd Jul 20194:58 pmRNSTR-1
16th Jul 20191:00 pmRNSAcquisition
2nd Jul 201912:38 pmRNSTR-1
12th Jun 20191:15 pmRNSTR-1
10th Jun 20194:59 pmRNSTR-1
31st May 20196:20 pmRNSTR-1
31st May 20196:14 pmRNSTR-1
30th May 20194:14 pmRNSTR-1
30th Apr 20197:00 amRNSHalf Year Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.